Cargando…

An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers

Pulmonary arterial hypertension (PAH), also known as Group 1 Pulmonary Hypertension (PH), is a PH subset characterized by pulmonary vascular remodeling and pulmonary arterial obstruction. PAH has an estimated incidence of 15–50 people per million in the United States and Europe, and is associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos-Gomes, Joana, Gandra, Inês, Adão, Rui, Perros, Frédéric, Brás-Silva, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333554/ https://www.ncbi.nlm.nih.gov/pubmed/35911521 http://dx.doi.org/10.3389/fcvm.2022.924873

Ejemplares similares

Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension
por: Santos-Gomes, Joana, et al.
Publicado: (2022)

Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension
por: Diekmann, Franziska, et al.
Publicado: (2021)

Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effects on Right Ventricular Function—Preclinical Studies
por: Balsa, André, et al.
Publicado: (2023)

Non-invasive Multimodality Cardiovascular Imaging of the Right Heart and Pulmonary Circulation in Pulmonary Hypertension
por: Hur, David J., et al.
Publicado: (2019)

Identification of Potential Biomarkers and Immune Infiltration Characteristics in Idiopathic Pulmonary Arterial Hypertension Using Bioinformatics Analysis
por: Zeng, Haowei, et al.
Publicado: (2021)

Management of pregnant patients with pulmonary arterial hypertension
por: Zhang, Xiao, et al.
Publicado: (2022)

The thromboxane receptor antagonist NTP42 promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload
por: Mulvaney, Eamon P., et al.
Publicado: (2022)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
por: Tan, Rubin, et al.
Publicado: (2022)

Validity of the ESC Risk Assessment in Idiopathic Pulmonary Arterial Hypertension in China
por: Gong, Su-Gang, et al.
Publicado: (2021)

Metabolic Reprogramming in the Heart and Lung in a Murine Model of Pulmonary Arterial Hypertension
por: Izquierdo-Garcia, Jose L., et al.
Publicado: (2018)

Prognostic Value of Gamma-Glutamyltransferase in Male Patients With Idiopathic Pulmonary Arterial Hypertension
por: Lu, Gang-Hua, et al.
Publicado: (2020)

Autoimmunity in Pulmonary Arterial Hypertension: Evidence for Local Immunoglobulin Production
por: Shu, Ting, et al.
Publicado: (2021)

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022)

Differences in disease severity and prognosis of exercise-induced right-to-left shunt between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients
por: Wang, Shang, et al.
Publicado: (2022)

Echocardiographic Prognosis Relevance of Attenuated Right Heart Remodeling in Idiopathic Pulmonary Arterial Hypertension
por: Zhao, Qin-Hua, et al.
Publicado: (2021)

Circulating microRNA-133a in Patients With Arterial Hypertension, Hypertensive Heart Disease, and Left Ventricular Diastolic Dysfunction
por: Koval, Sergiy M., et al.
Publicado: (2020)

Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
por: Lai, Jinzhi, et al.
Publicado: (2022)

Right Ventricular Function and Its Coupling With Pulmonary Circulation in Precapillary Pulmonary Hypertension: A Three-Dimensional Echocardiographic Study
por: Li, Yidan, et al.
Publicado: (2021)

Carbohydrate Antigen 125 Is a Biomarker of the Severity and Prognosis of Pulmonary Hypertension
por: Zhang, Yi, et al.
Publicado: (2021)

Sex Differences, Estrogen Metabolism and Signaling in the Development of Pulmonary Arterial Hypertension
por: Sun, Yanan, et al.
Publicado: (2021)

Glutaminolysis: A Driver of Vascular and Cardiac Remodeling in Pulmonary Arterial Hypertension
por: Mprah, Richard, et al.
Publicado: (2021)

Echocardiographic, Biochemical, and Electrocardiographic Correlates Associated With Progressive Pulmonary Arterial Hypertension
por: Zaky, Ahmed, et al.
Publicado: (2021)

Schistosome-Associated Pulmonary Arterial Hypertension: A Review Emphasizing Pathogenesis
por: Ferrari, Teresa Cristina Abreu, et al.
Publicado: (2021)

Relaxin Inhibits Ventricular Arrhythmia and Asystole in Rats With Pulmonary Arterial Hypertension
por: Martin, Brian, et al.
Publicado: (2021)

Construction of a diagnostic signature and immune landscape of pulmonary arterial hypertension
por: Duo, Mengjie, et al.
Publicado: (2022)

Pulmonary arterial hypertension associated with congenital heart disease: An omics study
por: Zhao, Maolin, et al.
Publicado: (2023)

Donepezil Ameliorates Pulmonary Arterial Hypertension by Inhibiting M2-Macrophage Activation
por: Qiu, Haihua, et al.
Publicado: (2021)

Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension
por: Richter, Manuel J., et al.
Publicado: (2021)

Pulmonary Arterial Hypertension and Consecutive Right Heart Failure Lead to Liver Fibrosis
por: Hamberger, Florian, et al.
Publicado: (2022)

Case report: Pulmonary arterial hypertension in ENG-related hereditary hemorrhagic telangiectasia
por: Liu, Dong, et al.
Publicado: (2022)

Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review
por: Lokhorst, Chantal, et al.
Publicado: (2022)

Transcription factors in the pathogenesis of pulmonary arterial hypertension—Current knowledge and therapeutic potential
por: Körbelin, Jakob, et al.
Publicado: (2023)

Persistent Pulmonary Hypertension of the Newborn: Pathophysiological Mechanisms and Novel Therapeutic Approaches
por: Martinho, Sofia, et al.
Publicado: (2020)

Case report: Thoughts on two cases of total anomalous pulmonary venous connection complicated with pulmonary artery hypertension
por: Yan, Ling, et al.
Publicado: (2023)

Circulating MicroRNA-505 May Serve as a Prognostic Biomarker for Hypertension-Associated Endothelial Dysfunction and Inflammation
por: Yang, Qinbo, et al.
Publicado: (2022)

Biomarker-based approach to determine etiology and severity of pulmonary hypertension: Focus on microRNA
por: Rogula, Sylwester, et al.
Publicado: (2022)

Echocardiographic Evaluation of Initial Ambrisentan Plus Phosphodiesterase Type 5 Inhibitor on Right Ventricular Pulmonary Artery Coupling in Severe Pulmonary Arterial Hypertension Patients
por: Lan, Wei-Fang, et al.
Publicado: (2022)

Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular Assessment
por: Alandejani, Faisal, et al.
Publicado: (2022)

Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan
por: Liang, Kae-Woei, et al.
Publicado: (2022)

Long-term outcomes of transcatheter Potts shunt in children with suprasystemic pulmonary arterial hypertension
por: Haddad, Raymond N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dg4sknqf6ok0iirgv2o8tge5fn